A continuing study of patients with "open negative" status at Battey State Hospital.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002648:Child; D003523:Cycloserine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005845:Georgia; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D011718:Pyrazinamide / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D014756:Viomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin